Wegovy maker Novo inks $16.5 billion acquisition of Catalent to boost supply Axios
Go here to read the rest:
Wegovy maker Novo inks $16.5 billion acquisition of Catalent to boost supply - Axios
Contact Us
-
Diet Specialists
Categories
-
Recent Posts
- Opinion | Ozempic and Wegovy Have Health Benefits Beyond Weight Loss – The New York Times
- Beyond Weight Loss: Five Yale Experts on the Benefits of Exercise – Yale School of Medicine
- Selling weight-loss and muscle-building supplements to minors in New York is now illegal – ABC News
- Colorado lawmakers light up state agencies opposed to paying for weight loss drugs: ‘Perhaps it’s time they go on a diet’ – CBS News
- Weight loss drugs will no longer be covered by insurance – WCNC.com
Archives
